Wealthfreq

NGENF Nervgen Consolidation continues Possible entry ahead

Long
OTC:NGENF   NervGen Pharma Corp.
Nice long ~2 year consolidation is in progress, recent reject from the top side of wedge will present entry opportunities

Entry target ~ 1.15-1.35 (1.25 average)

Interesting medical treatments currently in trials

Long term play

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.